Beam Therapeutics Inc.
BEAM
$28.62
$1.887.01%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -112.73M | -102.29M | -109.27M | -90.35M | -96.67M |
| Total Depreciation and Amortization | 5.56M | 5.54M | 5.53M | 5.44M | 5.48M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 32.81M | 16.86M | 25.33M | 29.30M | 28.67M |
| Change in Net Operating Assets | -7.12M | 3.44M | -25.47M | -20.75M | -25.60M |
| Cash from Operations | -81.48M | -76.45M | -103.88M | -76.37M | -88.13M |
| Capital Expenditure | -5.01M | -3.14M | -3.07M | -2.97M | -1.58M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -78.00K | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 70.74M | -167.28M | -122.02M | 129.25M | 26.28M |
| Cash from Investing | 65.66M | -170.41M | -125.09M | 126.28M | 24.70M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 0.00 | -201.00K |
| Issuance of Common Stock | 1.68M | 1.11M | 473.38M | 3.44M | 1.46M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.68M | 1.11M | 473.38M | 3.44M | 1.26M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -14.15M | -245.75M | 244.41M | 53.36M | -62.17M |